C

Choksi Laboratories Ltd
BSE:526546

Watchlist Manager
Choksi Laboratories Ltd
BSE:526546
Watchlist
Price: 111 INR -1.55%
Market Cap: ₹773.7m

Relative Value

526546 doesn't have a meaningful market cap.

The Relative Value of one CHOKSILA stock under the Base Case scenario is 121.2 INR. Compared to the current market price of 111 INR, Choksi Laboratories Ltd is Undervalued by 8%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CHOKSILA Relative Value
Base Case
121.2 INR
Undervaluation 8%
Relative Value
Price
C
Worst Case
Base Case
Best Case

Multiples Across Competitors

CHOKSILA Competitors Multiples
Choksi Laboratories Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Choksi Laboratories Ltd
BSE:526546
773.1m INR 1.8 46.7 7.8 17.9
UK
Relx PLC
LSE:REL
52.5B GBP 5.5 27.3 19.5 19.9
CA
Thomson Reuters Corp
TSX:TRI
75.2B CAD 7.4 31.1 13.1 18.6
UK
IHS Markit Ltd
F:0M3
37.9B EUR 9.5 36.5 31.2 46.7
IE
Experian PLC
LSE:EXPN
26.7B GBP 4.5 26.3 19.3 27.4
US
Verisk Analytics Inc
NASDAQ:VRSK
30.4B USD 10 33 18.8 23.3
US
CoStar Group Inc
NASDAQ:CSGP
28.3B USD 9.3 1 393.6 195.1 -337.3
US
Equifax Inc
NYSE:EFX
26.3B USD 4.4 39.9 15.8 25.3
US
Leidos Holdings Inc
NYSE:LDOS
23.9B USD 1.4 17 11.8 13.5
CH
SGS SA
SIX:SGSN
18.1B CHF 2.6 28.9 21.1 21.1
NL
Wolters Kluwer NV
AEX:WKL
19.6B EUR 3.2 17.6 11.7 15.5
P/E Multiple
Earnings Growth PEG
IN
C
Choksi Laboratories Ltd
BSE:526546
Average P/E: 154.4
46.7
N/A N/A
UK
Relx PLC
LSE:REL
27.3
14%
2
CA
Thomson Reuters Corp
TSX:TRI
31.1
1%
31.1
UK
I
IHS Markit Ltd
F:0M3
36.5
N/A N/A
IE
Experian PLC
LSE:EXPN
26.3
21%
1.3
US
Verisk Analytics Inc
NASDAQ:VRSK
33
8%
4.1
US
CoStar Group Inc
NASDAQ:CSGP
1 393.6
80%
17.4
US
Equifax Inc
NYSE:EFX
39.9
30%
1.3
US
Leidos Holdings Inc
NYSE:LDOS
17
10%
1.7
CH
SGS SA
SIX:SGSN
28.9
15%
1.9
NL
Wolters Kluwer NV
AEX:WKL
17.6
11%
1.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
C
Choksi Laboratories Ltd
BSE:526546
Average EV/EBITDA: 33.2
7.8
N/A N/A
UK
Relx PLC
LSE:REL
19.5
16%
1.2
CA
Thomson Reuters Corp
TSX:TRI
13.1
7%
1.9
UK
I
IHS Markit Ltd
F:0M3
31.2
N/A N/A
IE
Experian PLC
LSE:EXPN
19.3
10%
1.9
US
Verisk Analytics Inc
NASDAQ:VRSK
18.8
10%
1.9
US
CoStar Group Inc
NASDAQ:CSGP
195.1
92%
2.1
US
Equifax Inc
NYSE:EFX
15.8
12%
1.3
US
Leidos Holdings Inc
NYSE:LDOS
11.8
6%
2
CH
SGS SA
SIX:SGSN
21.1
10%
2.1
NL
Wolters Kluwer NV
AEX:WKL
11.7
7%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
C
Choksi Laboratories Ltd
BSE:526546
Average EV/EBIT: 22.9
17.9
N/A N/A
UK
Relx PLC
LSE:REL
19.9
11%
1.8
CA
Thomson Reuters Corp
TSX:TRI
18.6
10%
1.9
UK
I
IHS Markit Ltd
F:0M3
46.7
N/A N/A
IE
Experian PLC
LSE:EXPN
27.4
14%
2
US
Verisk Analytics Inc
NASDAQ:VRSK
23.3
11%
2.1
US
CoStar Group Inc
NASDAQ:CSGP
Negative Multiple: -337.3
403%
N/A
US
Equifax Inc
NYSE:EFX
25.3
18%
1.4
US
Leidos Holdings Inc
NYSE:LDOS
13.5
8%
1.7
CH
SGS SA
SIX:SGSN
21.1
13%
1.6
NL
Wolters Kluwer NV
AEX:WKL
15.5
9%
1.7